Amturnide FDA Approval History
FDA Approved: Yes (Discontinued) (First approved December 21, 2010)
Brand name: Amturnide
Generic name: aliskiren, amlodipine and hydrochlorothiazide
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: High Blood Pressure
Marketing Status: Discontinued
Amturnide (aliskiren, amlodipine and hydrochlorothiazide) is a direct renin inhibitor, calcium channel blocker and diuretic combination for the treatment of high blood pressure.
Development timeline for Amturnide
| Date | Article |
|---|---|
| Dec 22, 2010 | Approval Novartis Gains FDA Approval for Amturnide, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
